{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:36:50Z","timestamp":1789616210184,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":4347,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular &amp; Cellular Proteomics"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1074\/mcp.r800002-mcp200","type":"journal-article","created":{"date-parts":[[2008,7,29]],"date-time":"2008-07-29T23:09:04Z","timestamp":1217372944000},"page":"1780-1794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Proteomic Contributions to Personalized Cancer Care"],"prefix":"10.1016","volume":"7","author":[{"given":"John M.","family":"Koomen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Haura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerold","family":"Bepler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sutphen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Remily-Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaaron","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Hazlehurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Yeatman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne T.","family":"Hildreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fenstermacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.R800002-MCP200_bib1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.1125948","article-title":"Cancer biomarkers\u2014an invitation to the table","volume":"312","author":"Dalton","year":"2006","journal-title":"Science"},{"key":"10.1074\/mcp.R800002-MCP200_bib2","series-title":"Cancer Statistics 2008","article-title":"2008 Estimated US Cancer Deaths","author":"American Cancer Society","year":"2008"},{"key":"10.1074\/mcp.R800002-MCP200_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1098-2388(200007\/08)19:1<3::AID-SSU2>3.0.CO;2-S","article-title":"Ovarian cancer: epidemiology, biology, and prognostic factors","volume":"19","author":"Holschneider","year":"2000","journal-title":"Semin. Surg. Oncol."},{"key":"10.1074\/mcp.R800002-MCP200_bib4","first-page":"418","article-title":"Gynecological cancers","volume":"18","author":"Boente","year":"1999","journal-title":"Cancer Chemother. Biol. Response Modif."},{"key":"10.1074\/mcp.R800002-MCP200_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ssu.2980100403","article-title":"Etiology, biology, and epidemiology of ovarian cancer","volume":"10","author":"Baker","year":"1994","journal-title":"Semin. Surg. Oncol."},{"key":"10.1074\/mcp.R800002-MCP200_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/07853899509002463","article-title":"Is early detection of ovarian cancer possible?","volume":"27","author":"Schwartz","year":"1995","journal-title":"Ann. Med."},{"key":"10.1074\/mcp.R800002-MCP200_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.humrep.a136832","article-title":"The CA 125 tumour-associated antigen: a review of the literature","volume":"4","author":"Jacobs","year":"1989","journal-title":"Hum. Reprod."},{"key":"10.1074\/mcp.R800002-MCP200_bib8","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/jnci\/85.21.1748","article-title":"Elevation of multiple serum markers in patients with stage I ovarian cancer","volume":"85","author":"Woolas","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1074\/mcp.R800002-MCP200_bib9","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/1097-0142(20011201)92:11<2837::AID-CNCR10093>3.0.CO;2-5","article-title":"OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal","volume":"92","author":"van Haaften-Day","year":"2001","journal-title":"Cancer"},{"key":"10.1074\/mcp.R800002-MCP200_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1148\/radiology.192.1.8208918","article-title":"Screening for early ovarian cancer","volume":"192","author":"Taylor","year":"1994","journal-title":"Radiology"},{"key":"10.1074\/mcp.R800002-MCP200_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/172460089801300402","article-title":"CA 125: the past and the future","volume":"13","author":"Bast","year":"1998","journal-title":"Int. J. Biol. Markers"},{"key":"10.1074\/mcp.R800002-MCP200_bib12","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI110380","article-title":"Reactivity of a monoclonal antibody with human ovarian carcinoma","volume":"68","author":"Bast","year":"1981","journal-title":"J. Clin. Investig."},{"key":"10.1074\/mcp.R800002-MCP200_bib13","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1021\/pr070041v","article-title":"Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers","volume":"6","author":"Williams","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/mcp.R400006-MCP200","article-title":"Progress and challenges in screening for early detection of ovarian cancer","volume":"3","author":"Jacobs","year":"2004","journal-title":"Mol. Cell. Proteomics."},{"key":"10.1074\/mcp.R800002-MCP200_bib15","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1021\/pr070233q","article-title":"Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes","volume":"6","author":"Faca","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib16","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1021\/pr0604920","article-title":"Head-to-head comparison of serum fractionation techniques","volume":"6","author":"Whiteaker","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib17","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1002\/pmic.200401226","article-title":"Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project","volume":"5","author":"Li","year":"2005","journal-title":"Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","article-title":"Use of proteomic patterns in serum to identify ovarian cancer","volume":"359","author":"Petricoin","year":"2002","journal-title":"Lancet"},{"key":"10.1074\/mcp.R800002-MCP200_bib19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/pr050046x","article-title":"Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery","volume":"4","author":"Koomen","year":"2005","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib20","doi-asserted-by":"crossref","first-page":"10852","DOI":"10.1073\/pnas.0500426102","article-title":"Investigating diversity in human plasma proteins","volume":"102","author":"Nedelkov","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.R800002-MCP200_bib21","first-page":"2904","article-title":"Haptoglobin-\u03b1 subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry","volume":"9","author":"Ye","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib22","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1158\/0008-5472.CAN-04-0746","article-title":"Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1373\/clinchem.2005.065722","article-title":"Quantification of fragments of human serum inter-\u03b1-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption\/ionization-based immunoassay","volume":"52","author":"Song","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1074\/mcp.R800002-MCP200_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ijc.20928","article-title":"Classification of cancer types by measuring variants of host response proteins using SELDI serum assays","volume":"115","author":"Fung","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.R800002-MCP200_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI26022","article-title":"Differential exoprotease activities confer tumor-specific serum peptidome patterns","volume":"116","author":"Villanueva","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1074\/mcp.R800002-MCP200_bib26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1074\/mcp.M700397-MCP200","article-title":"A sequence-specific exopeptidase activity test (SSEAT) for \u201cfunctional\u201d biomarker discovery","volume":"7","author":"Villanueva","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib27","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/pr060344+","article-title":"Elevated levels of phosphorylated fibrinogen-\u03b1-isoforms and differential expression of other post-translationally modified proteins in the plasma of ovarian cancer patients","volume":"5","author":"Ogata","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib28","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1002\/pmic.200401321","article-title":"Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer","volume":"5","author":"Ahmed","year":"2005","journal-title":"Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib29","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1158\/1078-0432.CCR-07-0747","article-title":"Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer","volume":"13","author":"Jackson","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2006.12.032","article-title":"Discovery of cancer biomarkers through the use of mouse models","volume":"249","author":"Kuick","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1074\/mcp.R800002-MCP200_bib31","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1021\/ac034869m","article-title":"Ultra-high-efficiency strong cation exchange LC\/RPLC\/MS\/MS for high dynamic range characterization of the human plasma proteome","volume":"76","author":"Shen","year":"2004","journal-title":"Anal. Chem."},{"key":"10.1074\/mcp.R800002-MCP200_bib32","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1002\/pmic.200401246","article-title":"Characterization of the human blood plasma proteome","volume":"5","author":"Shen","year":"2005","journal-title":"Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib33","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1074\/mcp.M200066-MCP200","article-title":"Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry","volume":"1","author":"Adkins","year":"2002","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib34","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/pmic.200500358","article-title":"Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database","volume":"5","author":"Omenn","year":"2005","journal-title":"Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nbt1183","article-title":"Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study","volume":"24","author":"States","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1074\/mcp.R800002-MCP200_bib36","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1002\/pmic.200401333","article-title":"A proteomic study of the HUPO Plasma Proteome Project's pilot samples using an accurate mass and time tag strategy","volume":"5","author":"Adkins","year":"2005","journal-title":"Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib37","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1002\/pmic.200500140","article-title":"A functional annotation of subproteomes in human plasma","volume":"5","author":"Ping","year":"2005","journal-title":"Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib38","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2006-7-9-r80","article-title":"The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins","volume":"7","author":"Adachi","year":"2006","journal-title":"Genome Biol."},{"key":"10.1074\/mcp.R800002-MCP200_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/pr0703223","article-title":"A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers","volume":"7","author":"Gortzak-Uzan","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1021\/pr034015i","article-title":"Evaluation of shotgun sequencing for proteomic analysis of human plasma using HPLC coupled with either ion trap or Fourier transform mass spectrometry","volume":"2","author":"Wu","year":"2003","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<678::AID-IJC11>3.0.CO;2-2","article-title":"Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors","volume":"73","author":"Alaiya","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.R800002-MCP200_bib42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/(SICI)1522-2683(19990101)20:4\/5<1039::AID-ELPS1039>3.0.CO;2-4","article-title":"Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity","volume":"20","author":"Alaiya","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1074\/mcp.R800002-MCP200_bib43","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/pr060593y","article-title":"Large-scale proteomics analysis of human ovarian cancer for biomarkers","volume":"6","author":"Bengtsson","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib44","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/pmic.200300763","article-title":"Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers","volume":"4","author":"Wang","year":"2004","journal-title":"Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib45","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/pmic.200300670","article-title":"Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards","volume":"4","author":"Kuhn","year":"2004","journal-title":"Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib46","doi-asserted-by":"crossref","first-page":"17442","DOI":"10.1073\/pnas.0508782102","article-title":"Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure","volume":"102","author":"Hawkridge","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.R800002-MCP200_bib47","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/rcm.2391","article-title":"Targeted comparative proteomics by liquid chromatography\/matrix-assisted laser desorption\/ionization triple-quadrupole mass spectrometry","volume":"20","author":"Melanson","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1074\/mcp.R800002-MCP200_bib48","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1074\/mcp.M500331-MCP200","article-title":"Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins","volume":"5","author":"Anderson","year":"2006","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signaling","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature"},{"key":"10.1074\/mcp.R800002-MCP200_bib50","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJMra044389","article-title":"Tyrosine kinases as targets for cancer therapy","volume":"353","author":"Krause","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/mcp.R800002-MCP200_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(03)01077-8","article-title":"Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems","volume":"116","author":"Pawson","year":"2004","journal-title":"Cell"},{"key":"10.1074\/mcp.R800002-MCP200_bib52","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.molcel.2007.05.031","article-title":"High-throughput phosphotyrosine profiling using SH2 domains","volume":"26","author":"Machida","year":"2007","journal-title":"Mol. Cell"},{"issue":"suppl.","key":"10.1074\/mcp.R800002-MCP200_bib53","doi-asserted-by":"crossref","first-page":"239s","DOI":"10.1200\/JCO.2003.10.589","article-title":"David A. Karnofsky Award lecture. Imatinib as a paradigm of targeted therapies","volume":"21","author":"Druker","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1074\/mcp.R800002-MCP200_bib54","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1158\/0008-5472.CAN-05-1855","article-title":"Somatic mutations of the protein kinase gene family in human lung cancer","volume":"65","author":"Davies","year":"2005","journal-title":"Cancer Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib55","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.290.16.2149","article-title":"Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial","volume":"290","author":"Kris","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1074\/mcp.R800002-MCP200_bib56","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.2004.11.057","article-title":"Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer","volume":"22","author":"Perez-Soler","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1074\/mcp.R800002-MCP200_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/mcp.R800002-MCP200_bib58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/mcp.R800002-MCP200_bib59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A small molecule-kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1074\/mcp.R800002-MCP200_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.R800002-MCP200_bib61","doi-asserted-by":"crossref","first-page":"13283","DOI":"10.1073\/pnas.0702654104","article-title":"The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib","volume":"104","author":"Hantschel","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.R800002-MCP200_bib62","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood-2007-07-102061","article-title":"Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets","volume":"110","author":"Rix","year":"2007","journal-title":"Blood"},{"key":"10.1074\/mcp.R800002-MCP200_bib63","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","article-title":"Oncogenic pathway signatures in human cancers as a guide to targeted therapies","volume":"439","author":"Bild","year":"2006","journal-title":"Nature"},{"key":"10.1074\/mcp.R800002-MCP200_bib64","doi-asserted-by":"crossref","first-page":"4365s","DOI":"10.1158\/1078-0432.CCR-06-1005","article-title":"Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents","volume":"12","author":"Lynch","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib65","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrm1939","article-title":"Interpreting the protein language using proteomics","volume":"7","author":"Jensen","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1074\/mcp.R800002-MCP200_bib66","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1126\/science.278.5346.2075","article-title":"Signaling through scaffold, anchoring, and adaptor proteins","volume":"278","author":"Pawson","year":"1997","journal-title":"Science"},{"key":"10.1074\/mcp.R800002-MCP200_bib67","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1073\/pnas.0603948103","article-title":"Phosphoproteomic analysis of Her2\/neu signaling and inhibition","volume":"103","author":"Bose","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.R800002-MCP200_bib68","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1182\/blood-2005-08-3399","article-title":"A common phosphotyrosine signature for the Bcr-Abl kinase","volume":"107","author":"Goss","year":"2006","journal-title":"Blood"},{"key":"10.1074\/mcp.R800002-MCP200_bib69","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nbt1046","article-title":"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells","volume":"23","author":"Rush","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1074\/mcp.R800002-MCP200_bib70","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.leukres.2006.01.001","article-title":"Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes","volume":"30","author":"Walters","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ccr.2006.06.002","article-title":"Activating alleles of JAK3 in acute megakaryoblastic leukemia","volume":"10","author":"Walters","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1074\/mcp.R800002-MCP200_bib72","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","article-title":"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer","volume":"131","author":"Rikova","year":"2007","journal-title":"Cell"},{"key":"10.1074\/mcp.R800002-MCP200_bib73","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nmeth917","article-title":"Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains","volume":"3","author":"Dierck","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1074\/mcp.R800002-MCP200_bib74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-59745-255-7_14","article-title":"Quantitative proteomic analysis of phosphotyrosine-mediated cellular signaling networks","volume":"359","author":"Zhang","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1074\/mcp.R800002-MCP200_bib75","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nbt1005","article-title":"Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics","volume":"22","author":"Blagoev","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1074\/mcp.R800002-MCP200_bib76","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1073\/pnas.0608638104","article-title":"Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks","volume":"104","author":"Wolf-Yadlin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.R800002-MCP200_bib77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/14789450.4.1.13","article-title":"Quantitative proteomic approaches for studying phosphotyrosine signaling","volume":"4","author":"Ding","year":"2007","journal-title":"Expert Rev. Proteomics"},{"key":"10.1074\/mcp.R800002-MCP200_bib78","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nchembio.2007.59","article-title":"High-content single-cell drug screening with phosphospecific flow cytometry","volume":"4","author":"Krutzik","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1074\/mcp.R800002-MCP200_bib79","doi-asserted-by":"crossref","first-page":"16153","DOI":"10.1073\/pnas.0607973103","article-title":"Isoelectric focusing technology quantifies protein signaling in 25 cells","volume":"103","author":"O'Neill","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.R800002-MCP200_bib80","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/mcp.R800002-MCP200_bib81","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1074\/mcp.R800002-MCP200_bib82","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1074\/mcp.R800002-MCP200_bib83","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.3816\/CLM.2007.s.017","article-title":"Emerging data on the use of anthracyclines in combination with Bortezomib in multiple myeloma","volume":"7","author":"Voorhees","year":"2007","journal-title":"Clin. Lymphoma Myeloma"},{"key":"10.1074\/mcp.R800002-MCP200_bib84","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1634\/theoncologist.12-8-978","article-title":"Clinical Impact of Bortezomib in frontline regimens for patients with multiple myeloma","volume":"12","author":"Manochakian","year":"2007","journal-title":"Oncologist"},{"key":"10.1074\/mcp.R800002-MCP200_bib85","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","article-title":"Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition","volume":"67","author":"Meister","year":"2007","journal-title":"Cancer Res."},{"key":"10.1074\/mcp.R800002-MCP200_bib86","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1200\/JCO.2006.08.2099","article-title":"Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer","volume":"25","author":"Simon","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1074\/mcp.R800002-MCP200_bib87","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa065411","article-title":"DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer","volume":"356","author":"Zheng","year":"2007","journal-title":"N. Engl. J. Med."}],"container-title":["Molecular &amp; Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620312676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620312676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.R800002-MCP200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:25:48Z","timestamp":1761524748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620312676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":87,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1535947620312676"],"URL":"https:\/\/doi.org\/10.1074\/mcp.r800002-mcp200","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic Contributions to Personalized Cancer Care","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.R800002-MCP200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}